Immune system alterations in lung cancer patients

International Journal of Immunopathology and Pharmacology

Volumn 16, Issue 2, 2003, Pages 167-174

  Mazzoccoli, G ^a   Grilli, M ^a   Carughi, S ^a   Puzzolante, F ^a   De Cata, A ^a   La Viola, M ^a   Giuliani, A ^a   Urbano, N ^a   Tarquini, R ^b   Perfetto, F ^b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Circadian rhythm; Immune response; Interleukin 2; Lung cancer; Lymphocyte subpopulations

Indexed keywords

CD16 ANTIGEN; CD20 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR 1; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; AGED; AREA UNDER THE CURVE; ARTICLE; B LYMPHOCYTE; BLOOD LEVEL; BLOOD SAMPLING; CALCULATION; CANCER IMMUNOTHERAPY; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPPRESSOR CELL; T LYMPHOCYTE;

EID: 10744228969     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200301600211     Document Type: Article

References (36)

1. Abo T. and K. Kumagi. 1978. Surface studies of immunolobulins on human B lymphocytes. III. Physiological variations of SIg+ cells in peripheral blood. Clin. Exp. Immunol. 33:441.
2. Abo T., T. Kawate and K. Itoh. 1979. Characterization of rhythms and cell components in circadian variation of human and mouse lympocytes. Chronobiologia 6:71.
3. Ritchie A.W., I. Oswald, H.S. Miclem, J.E. Boyd, R.A. Elton, E. Jazwinska and K. James. 1983. Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies. BMJ 286:1773.
4. Bertough J.V., P.J. Roberts Thomson and J. Bradley. 1983. Diurnal variation of lymphocyte subsets identified by monoclonal antibodies. BMJ 286:1171.
5. Signore A., P. Cugini and C. Letizia. 1985. Study of the diurnal variation of human lymphocyte subsets. J. Clin. Lab. Immunol. 17:25.
6. Cugini P., M. Cavallini, P. Pozzilli, M. Palestini, C. Letizia, L. Di Palma and P. Battisti. 1990. T lymphocyte subpopulations, plasma cortisol and ciclosporin in kidney-transplanted subjects: a chronobiologic approach to the adrenal-immune system. Contrib. Nephrol. 83:264.
7. Cugini P., P. Lucia, L. Di Palma, P. Pozzilli, M. Re, R. Canova, L. Gasbarrone and A. Cianetti. 1991. Temporal interrelationships between circadian rhythms of vasoactive intestinal peptide and T lymphocyte subpopulations. J. Clin. Lab. Immunol. 34:49.
8. Cugini P., M. Cavallini, P. Pozzilli, C. Letizia, M. Sepe and L. Di Palma. 1991. Circadian rhythm of T lymphocyte subsets, cortisol and cyclosporin in kidney transplanted subjects. Nephrol. Dial. Transplant. 6:512.
9. Born J., T. Lange, K. Hansen, M. Molle and H.L. Fehm. 1997. Effects of sleep and circadian rhythm on human circulating immune cells. J. Immunol. 158:4454.
10. Born J., D. Uthgenannt, C. Dodt, D. Nunninghoff, E. Ringvolt, T. Wagner and H.L. Fehm. 1995. Cytokine production and lymphocyte subpopulations in aged humans. An assessment during nocturnal sleep. Mech. Ageing Dev. 13:113.
11. Stein R., R.M. Sharkey and D.M. Goldenberg. 1992. Haematological effects of radioimmunotherapy in cancer patients. B. J. Haematologica 80:68.
12. Lores Vazquez B., M. Pacheco Carracedo, J. Oliver Morales, P. Parada Gonzalez and F. Gambon Deza. 1996. Lymphocyte subpopulations of regional lymph nodes in human colon and gastric adenocarcinomas. Cancer Immunol. Immunother. 42:339.
13. Cartei G., P.G. Sala, M. Sanzari, V. Ceschia, L. Clocchiatti, A. Sibau, S. Dona, M. Giovannoni and E. Vigevani. 1993. Reduced lymphocyte subpopulations in patients with advanced or disseminated melanoma. J. Am. Acad. Dermatol. 28:738.
14. Nelson W., Y.L. Tong and F. Halberg. 1979. Methods for cosinorrhytmometry. Chronobiologia 6:305.
15. Bingham C., B. Arbogast, G. Cornelissen, J.K. Lee and F. Halberg. 1982. Inferential statistical methods for estimating and comparing cosinor parameters. Chronobiologia 9:397.
16. Grimm E.A., A. Mazumder, H.Z. Zhang and S.A. Rosenberg. 1982. Lymphokine-activated killer cell phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J. Exp. Med. 155:1823.
17. Topalian S.L., D. Solomon and S.A. Rosenberg. 1989. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J. Immunol. 142:3714.
18. Trinchieri G. 1989. Biology of natural killer cells. Adv Immunol 47:187.
19. Salvo G., P. Samoggia, R. Masciulli, G. Boccoli, P. Allavena, G. Mariani, A. Bullo, E. Montesoro, D. Bulgarini and P. Carlini. 1992. Interleukin-2 bolus therapy induces immediate and selective disappearence from peripheral blood of all lymphocyte subpopulations displayng natural killer activity: role of cell adhesion to endothelium. Eur. J. Cancer 28:818.
20. Wick G., L.A. Huber, Q. Xu, E. Jarosh, D. Schonitzer and G. Jurgens. 1991. The decline of the immune response during aging: the role of an altered lipid metabolism. Ann. N. Y. Acad. Sci. 621:277.
21. Goto M. and K. Nishioka. 1989. Age and sex-related changes of the lymphocyte subsets in healthy individuals: an anlysis by two dimensional flow cytometry. J. Gerontology 44:M51-M56.
22. Yamashiki M., A. Nishimura, Y. Kosaka and S.P. James. 1994. Two-color analysis of peripheral lymphocyte surface antigens in inherently healthy adults. J. Clin. Lab. Anal. 8:22.
23. Stulnig T., C. Maczek, G. Bock, O. Majdic and G. Wick. 1995. Reference intervals for human peripheral blood lymphocyte subpopulations from 'healthy' young and aged subjects. Int. Arch. Allergy Immunol. 108:205.
24. Cosimi A.B., R.B. Colvin and R.C. Burton. 1981. Use of monoclonal antibodies to T cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N. Engl. J. Med. 305:308.
25. Ratte J., F. Halberg and J.F.W. Kuhl. 1973. Circadian variation in the rejection of rat kidney allografts. Surgery 73:102.
26. Knapp M.S., J.R. Cove Smith and R. Dugdale. 1979. Possible effect of time on renal allograft rejection. BMJ 32:75.
27. - lymphocytes. Immunology 70:351.
28. Sleasman J.W., C. Morimoto, S.F. Schlossman and T.F. Tedder. 1990. The role of functionally distinct helper T lymphocyte subpopulations in the induction of human B cell differentiation. Eur. J. Immunol. 2:1357.
29. Macintyre E.A. and F. Sigaux. 1989. T cell receptor γδ: current state of knowledge and potential clinical applications in haematology. Br. J. Haematology 73:2.
30. Kaver I., M. Pecht, N. Trainin, A. Greenstein and Z. Braf. 1992. T lymphocyte subsets and function in the peripheral blood of patients with urological cancer. Oncology 49:108.
31. Takahashi M., S. Fujimoto, M. Takai, K. Ohno, F. Endoh, Y. Masuda and G. Obata. 1992. Two-color flow cytometric analysis of splenic lymphocyte subpopulations in patients with gastric cancer. Surg. Today 22:35.
32. Jackson P.A., M.A. Green, C.G. Marks, R.J. King, R. Hubbard and M.G. Cook. 1996. Lymphocyte subset infiltration patterns and HLA antigen status in colorectal carcinomas and adenomas. Gut 38:85.
33. Brandau S., J. Riemensberger, M. Jacobsen, D. Kemp, W. Zhao, X. Zhao, D. Jocham, T.L. Ratliff and A. Bohle. 2001. NK cells are essential for effective BCG immunotherapy. Int. J. Cancer 92:697.
34. Bensussan A., J.F. Lagabrielle and L. Degos. 1989. TcRgd bearing lymphocyte clones with lymphokine activated killer activity against autologous laeukemic cells. Blood 15:135.
35. - lymphocytes associated with neutropenia. Leukemia and Lymphoma 14:429.
36. Kobayashi H., Y. Tanaka, J. Yagi, H. Toma and T. Uchiyama. 2001. Gamma/delta T cells provide innate immunity against renal cell carcinoma. Cancer Immunol. Immunother. 50:115.